ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 23925 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 23925; 2) Community: the network communities that were significantly associated with the response to NSC 23925; 3) Molecule: the relationships between components within communities and NSC 23925; 4) MDR: the compounds that were significantly associated with the NSC 23925.

NSC Compound Enrichment Correlation
NSC 671030 N8-Actinomycin D 0.00336064452966826 0.34750582
NSC 724784 (1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.0 0.00336064452966826 0.28815262
NSC 735332 Null 0.00336064452966827 0.20903434
NSC 191924 Null 0.0033606445296683 0.052910421
NSC 132230 Null 0.00337662564965909 0.33509388
NSC 326408 Rocaglamide (FR AGLAIA ELLIPTIFOLIA) 0.00337662564965909 0.36397237
NSC 706995 Entinostat 0.00366577979610622 0.16019088
NSC 748903 [(20S)-20-(N,N-dimethylamino)- 3a-(tigloylamino)-5a-preg-2a,4a-diol] 0.00366577979610622 0.37478442
NSC 755423 Null 0.00366577979610622 0.26350193
NSC 600392 Antibiotic mixture B-1625 FA2 & FA3 0.0041872854493286 0.28433571
Total:74  Current:5    [First] [Prev] [Next] [Last]